Authors : Sai Ravi Kiran Biri, S L V Sankeerthi C H, Sandhya Rani T, Rajkumar Gundu, Aravind Vadlakonda
DOI : 10.18231/j.ijcbr.2021.061
Volume : 8
Issue : 4
Year : 2021
Page No : 285-288
Background: Diabetes is one of the leading causes for end stage renal disease and nephropathy. Increases of blood urea and serum creatinine are due to abnormal renal function and also reduction in glomerular filtration rate. So, Urea and Creatinine are the ideal biomarkers to correlate the progression of diabetic nephropathy. Aim of the study is to evaluate the blood urea & serum creatinine with HbA1C in Diabetes mellitus patients.
Materials and Methods: A total of 50 cases and 30 controls were selected in our study. Blood samples were collected for blood urea, serum creatinine, HbA1C, Fasting plasma glucose and Post prandial blood sugar with age limit of 35-65 years. Mean ±SD was calculated for all these parameters.
Results: Blood urea and Serum creatinine are statistically significant in Diabetic patients when compared to the controls.
Conclusion: Our study shows that blood urea and serum creatinine can be used as biomarkers in the early detection of diabetic nephropathy. These parameters help in reducing the severity of renal failure.
Keywords: Glycosylated hemoglobin, Diabetes mellitus, Renal nephropathy.